Menu
GeneBe

11-105612350-C-T

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 3P and 1B. PM2PP2BP4

The NM_000829.4(GRIA4):c.163C>T(p.Pro55Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 32)

Consequence

GRIA4
NM_000829.4 missense

Scores

2
7
7

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 7.57
Variant links:
Genes affected
GRIA4 (HGNC:4574): (glutamate ionotropic receptor AMPA type subunit 4) Glutamate receptors are the predominant excitatory neurotransmitter receptors in the mammalian brain and are activated in a variety of normal neurophysiologic processes. These receptors are heteromeric protein complexes composed of multiple subunits, arranged to form ligand-gated ion channels. The classification of glutamate receptors is based on their activation by different pharmacologic agonists. The subunit encoded by this gene belongs to a family of AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate)-sensitive glutamate receptors, and is subject to RNA editing (AGA->GGA; R->G). Alternative splicing of this gene results in transcript variants encoding different isoforms, which may vary in their signal transduction properties. Some haplotypes of this gene show a positive association with schizophrenia. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, GRIA4
BP4
Computational evidence support a benign effect (MetaRNN=0.38955808).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GRIA4NM_000829.4 linkuse as main transcriptc.163C>T p.Pro55Ser missense_variant 3/17 ENST00000282499.10

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GRIA4ENST00000282499.10 linkuse as main transcriptc.163C>T p.Pro55Ser missense_variant 3/175 NM_000829.4 A1P48058-1

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
30
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsJan 03, 2024The c.163C>T (p.P55S) alteration is located in exon 3 (coding exon 2) of the GRIA4 gene. This alteration results from a C to T substitution at nucleotide position 163, causing the proline (P) at amino acid position 55 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Uncertain
0.063
T
BayesDel_noAF
Benign
-0.15
Cadd
Uncertain
24
Dann
Uncertain
1.0
Eigen
Uncertain
0.46
Eigen_PC
Uncertain
0.59
FATHMM_MKL
Pathogenic
0.98
D
M_CAP
Benign
0.019
T
MetaRNN
Benign
0.39
T;T;T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.92
T
MutationTaster
Benign
1.0
D;D;D;D;D;D;D
PrimateAI
Pathogenic
0.88
D
PROVEAN
Benign
0.020
N;N;N;N;N;N;N;N;N;N;N
REVEL
Uncertain
0.37
Sift
Uncertain
0.019
D;T;D;T;T;D;D;T;T;T;T
Sift4G
Benign
0.46
T;T;T;T;T;T;T;T;T;T;T
Polyphen
0.027, 0.92
.;.;.;B;P;.;.;.;.;P;B
Vest4
0.64, 0.66, 0.69, 0.68, 0.64, 0.66
MutPred
0.47
Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);Gain of catalytic residue at P55 (P = 0.0633);
MVP
0.45
MPC
0.31
ClinPred
0.92
D
GERP RS
5.8
Varity_R
0.081
gMVP
0.68

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr11-105483077; API